Europa- Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for Irbesartan Hydrochlorothiazide Winthrop til Sanofi Pharma Bristol- Myers Squibb SNC den 19. januar 2007.
The European Commission granted a marketing authorisation valid throughout the EU for Irbesartan Hydrochlorothiazide Winthrop to Sanofi Pharma Bristol-Myers Squibb SNC on 19 January 2007.